XNAS
Pulsenmore Ltd is an emerging medical device company engaged in the research, development, manufacturing, marketing, and sale of non-invasive portable ultrasound solutions for home use. Its products include the Pulsenmore ES and Pulsenmore FC, along with the early-stage Pulsenmore MC, collectively referred to as Pulsenmore Products, enabling remote ultrasound scans in gynecology and other fields such as pulmonary, cardiology, and urology through telemedicine. The Company operates in a single segment focused on developing and commercializing portable ultrasound technologies, with Israel contributing the majority of its revenue.
Pulsenmore’s first-half results remain weak, with **$2M** of revenue and **$1.83** per-share loss signaling a still-immature commercial model. With no clear catalyst or guidance, this reads as a high-risk, early-stage story rather than an investable growth inflection.
AI-generated summary — powered by BigEarnings.
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-31 | H1 2026 | — | -1.83 | — | $2.0M | — | +3.50% | — | — |
| 2026-03-30 | FY 2025 | — | -0.77 | — | $12.5M | — | +0.56% | -2.22% | -1.39% |
Showing last 2 quarters.